Skip to main content
. 2024 Jan 30;16(3):585. doi: 10.3390/cancers16030585
5-FU 5-Fluorouracil
AHR Aryl hydrocarbon receptor
AP-1 Activator protein-1 transcription factor
BAD BCL2-associated agonist of cell death
BAX BCL2-associated X
BCL2 B-cell lymphoma 2
CDC2 Cyclin-dependent kinase 2
CDC25C Cell Division Cycle 25C
CDK2 Cyclin D-dependent kinase 2
CDK4 Cyclin D-dependent kinase 4
CDKN1A Cyclin-dependent kinase inhibitor 1A
Chk2 Checkpoint kinase 2
DNA Deoxyribonucleic Acid
EGFR Epidermal growth factor receptor
EMT Epithelial–mesenchymal transition
FADD Fas-associated death domain
GRADE Grading of Recommendations Assessment, Development, and Evaluation
HIF Hypoxia-inducible factor
JNK c-Jun N-terminal kinase
KMP Kaempferol
MAPK Mitogen-activated protein kinase
MMPs Matrix metalloproteinases
mRNA Messenger ribonucleic acid
mTOR Mammalian target of rapamycin
Nrf2 Nuclear factor erythroid 2-related factor 2
PKB Protein kinase B, also known as AKT
ROS Reactive oxygen species
Smad2 Mothers against decapentaplegic homolog 2
Smad4 Mothers against decapentaplegic homolog 4
STAT Signal transducer and activator of transcription
TFEB Transcription factor EB
TGF-β1 Transforming growth factor-β1
VEGF Vascular endothelial growth factor